 Connection
Benedetto Mungo to Neoadjuvant Therapy
This is a "connection" page, showing publications Benedetto Mungo has written about Neoadjuvant Therapy.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.525 |
|
|
|
-
Mungo B, Molena D, Stem M, Yang SC, Battafarano RJ, Brock MV, Lidor AO. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality? Dis Esophagus. 2015 Oct; 28(7):644-51.
Score: 0.404
-
Molena D, Sun HH, Badr AS, Mungo B, Sarkaria IS, Adusumilli PS, Bains MS, Rusch VW, Ilson DH, Rizk NP. Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. Dis Esophagus. 2014 May-Jun; 27(4):355-9.
Score: 0.095
-
Shah SP, Xu T, Hooker CM, Hulbert A, Battafarano RJ, Brock MV, Mungo B, Molena D, Yang SC. Why are patients being readmitted after surgery for esophageal cancer? J Thorac Cardiovasc Surg. 2015 May; 149(5):1384-9; discussion 1389-91.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|